| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647577 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 11 Pages |
Abstract
The study demonstrates a small but significant benefit in achieving asthma control from an add-on LABA as an FDC, compared with a separate inhaler and this supports current guideline recommendations.
Keywords
ARRAORFDAFDCOCsMPRSABAICSBDPLTRACPRDAsthmaLeukotriene receptor antagonistLong-acting β-agonistShort-acting β-agonistBeclomethasone dipropionateClinical Practice Research DatalinkFixed-dose combinationNICEFood and Drug AdministrationLABAconfidence intervalNational Institute for Health and Care ExcellenceMedication possession ratioadjusted odds ratioSMARTChildInhaled corticosteroidInhaled corticosteroidsoral corticosteroids
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Steve MD, Kathryn PhD, Clare MD, Mike PhD, Elizabeth V. DVM, Anne MSc, David B. FRCGP, Respiratory Effectiveness Group Respiratory Effectiveness Group,